Previous Article | Next Article 
Journal of Virology, October 2001, p. 9623-9632, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9623-9632.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Frequency of Spontaneous Mutations in an Avian
Hepadnavirus Infection
Irmgard
Pult,
Nathan
Abbott,
Yong-Yuan
Zhang, and
Jesse
Summers*
Department of Molecular Genetics and
Microbiology, The University of New Mexico School of Medicine,
Albuquerque, New Mexico
Received 1 June 2001/Accepted 20 July 2001
 |
ABSTRACT |
In this study, we measured the frequency of revertants of a
cytopathic strain of the duck hepatitis B virus that bears a single nucleotide substitution in the pre-S envelope protein open reading frame, resulting in the amino acid substitution G133E. Cytopathic virus
mixed with known amounts of a genetically marked wild-type virus was
injected into ducklings. Virus outgrowth was accompanied by a
coselection of wild-type and spontaneous revertants during recovery of
the ducklings from the acute liver injury caused by death of the
G133E-infected cells. The frequency of individual revertants in the
selected noncytopathic virus population was estimated by determining
the ratio of each revertant to the wild-type virus. Spontaneous
revertants were found to be present at frequencies of 1 × 10
5 to 6 × 10
5 per G133E genome
inoculated. A mathematical model was used to estimate that the mutation
rate was 0.8 × 10
5 to 4.5 × 10
5
per nucleotide per generation.
 |
INTRODUCTION |
Duck hepatitis B virus (DHBV)
belongs to the family Hepadnaviridae, a small group of
enveloped viruses which cause persistent liver infections and replicate
their DNA genomes through reverse transcription of an RNA intermediate
(26). Because of the involvement of reverse transcription,
the replication of the viral genome is assumed to be error prone and to
give rise to a high degree of genetic variation. In humans, HBV can
cause acute and chronic liver disease, and genetic variation is
believed to be related to the clinical outcome of hepadnavirus
infection (for a review, see reference 8). In recent
years, it has become more fully appreciated how the presence of a
complex mixture of variants in the virus population within a single
host, the quasispecies, may enable rapid adaptation to changing
environments (5), in particular to selection forces such
as antiviral drugs (1), vaccines (4),
immunomodulatory substances (20), and other changes in the
host's immune response, leading to the emergence of various resistance
and escape mutants (25).
Major mechanisms contributing to the complexity of the viral
quasispecies are the generation of errors during viral genome replication, environmentally induced mutations, and recombination. Of
these, errors in replication are thought to constitute the greatest
source for generating variants. The frequency of replication errors in
hepadnaviruses is a function of the fidelities of three polymerization
reactions which occur during the life cycle in two different
compartments. In the nucleus, covalently closed circular DNA
(cccDNA)-templated positive-strand RNA synthesis is carried out by
cellular RNA polymerase (RNA pregenome synthesis), and in the viral
core particles, RNA-templated negative-strand DNA synthesis and
DNA-templated positive-strand DNA synthesis are both carried out by
reverse transcriptase. The relative contributions of the various
enzymes involved in different polymerization steps to the overall
mutation rate of the virus are not known.
In spite of the reported widespread occurrence of genetic variation in
hepadnavirus infection, little is known about the natural mutation rate
of HBV, and most estimates are extrapolations from that of RNA viruses
and retroviruses, which have been more intensively studied (6, 9,
19, 23). Experimental approaches used to measure variation in
hepadnaviruses have generally focused on estimating the variation that
has occurred within infected individuals over a known period of time
(2, 3, 7, 10, 22). Two difficulties in interpreting such
measurements are the lack of knowledge about selective pressures that
may have influenced the frequency of any particular variant in the
virus population and the history of the dynamic state of virus
replication during the interval considered. Since the frequency of any
unselected variant in the population will reflect the number of
generations of virus replication that have occurred, and fitness
selection depends on the dynamics of the infection (29),
it is difficult to relate measurements of mutant frequency to the
mutation rate per generation.
In this study, we determined the frequency of mutations at several
individual sites in the DHBV genome by assaying the occurrence of
spontaneous reversion of a single-base-change cytopathic variant of
DHBV (14, 15, 17) in an experimental infection of young ducklings. Because revertants could be coselected in parallel with a
known amount of wild-type (WT) virus (16), we were able to
measure the frequency of revertants relative to the added WT genomes.
We used reasonable assumptions to construct a mathematical model for
relating the frequency of revertants to the mutation rate per generation.
 |
MATERIALS AND METHODS |
Plasmids.
The DHBV type 16 (DHBV-16) WT genome was a
head-to-tail-dimer construct derived from that sequenced by Mandart et
al. (18) and cloned into pSP65. The G133E mutant viral
genome carried a single-amino-acid codon change from glycine to
glutamic acid at residue 133 (G133E) in the large envelope protein
(14) produced by site-directed mutagenesis of a guanylate
residue at nucleotide (nt) 1198 to adenylate (G1198A). In addition,
this mutant genome carried a silent nucleotide substitution of
cytidylate at nt position 1178 to adenylate (C1178A), resulting in the
destruction of a SmaI site present in the WT genome. The
presence or absence of the SmaI site was used to determine
the virus variant in the duckling serum. Neither nucleotide
substitution altered the DHBV polymerase open reading frame, which
overlaps the pre-S region.
Cell culture and transfection.
WT and mutant viruses were
produced by transfection of the chicken hepatoma cell line LMH
(13) with respective DHBV DNA as previously described
(27). Supernatants from the transfected LMH cells were
collected daily from day 3 to day 10 posttransfection, clarified by
low-speed centrifugation, and stored at 4°C before use. The titer of
virus of the supernatants was determined by Southern blot hybridization
with a 32P-labeled riboprobe following selective DNA
extraction from enveloped virus particles (14).
Hybridization was quantitated by phosphorimaging (Molecular Dynamics,
Sunnyvale, Calif.). Virus used for injection was concentrated by
precipitation with 10% (wt/vol) polyethylene glycol 8000 (Sigma, St.
Louis, Mo.) (15).
Animals and infections.
One-day-old White Pekin ducklings
obtained from Metzer Farms (Redland, Calif.) were used in experiment 1, and ducklings from Privett Hatchery (Portales, N. Mex.) were used in
experiment 2. Ducklings testing negative for DHBV DNA by dot
hybridization were infected by intravenous injection of a volume of 300 µl of a suspension of DHBV on day 4 posthatching. All birds were fed
an unrestricted diet and received humane care throughout the study in
accordance with guidelines issued by the National Institutes of Health.
In experiment 1, six groups of four ducklings each were infected with
inocula of G133E at a dose of 108 viral genomes per bird
either alone or combined with WT DHBV added in ratios of
10
2 to 10
6. One group of three ducklings
was infected with WT virus only, at a dose of 108. Three
birds that served as uninfected controls received no inoculum. In
experiment 2, ducklings were infected with a mixture of 107
genomes of WT DHBV combined with 107 genomes of G133E,
E133G, D129E, G133K, Q135R, Q135H, or T140I. The birds were monitored
for weight change (experiment 1) and viremia (experiments 1 and 2) for
up to 25 days after infection in experiment 1 and up to 11 days after
infection in experiment 2. DHBV DNA in the serum was detected by dot
hybridization using a 32P-labeled riboprobe specific for
the detection of the viral minus strand (24) and
quantified by phosphorimaging.
PCR amplification, determination of virus variants, and cloning
of DHBV DNA from PCR products.
Amplification was performed on DNA
derived from the equivalent of 2.5 µl of serum by mixing serum
samples with an equal amount of 10 mM Tris-HCl (pH 7.4)-1 mM EDTA and
incubating the mixture at 96°C for 10 min (21). The
entire pre-S region was amplified by using sense primer P1 and reverse
primer P2. A restriction site for ApaI (New England BioLabs,
Beverly, Mass.) was introduced into the 5' end of P1 (underlined
below). In addition, this primer was biotinylated. Sequences of the
primers were as indicated: P1
5'-CGCGGGGCCCAAGAGCATTTCCTA, nt 584 to 603, sense; P2, 5'-CCGATTAGGCCAGCTAGTAT, nt 1324 to 1305, reverse. A 741-bp fragment was produced from the viral DNA template by
using 2.5 U of Taq DNA polymerase (Promega, Madison, Wis.)
for 35 cycles of 15 s at 95°C, 15 s at 55°C, and 30 s at
72°C in a GeneAmp PCR System 9700 (Perkin-Elmer Cetus, Norwalk,
Conn.).
The PCR product from the WT DHBV contained a single
SmaI
site yielding two digestion products, one of 592 and one of 149 bps,
however, this restriction site was absent in PCR products derived
from
the mutant G133E genome. A pGEM-7Zf(+) vector (600 ng) (Promega),
carrying a single
SmaI site in its sequence, was introduced
in
the digestion reaction with
SmaI as an internal control
for complete
digestion.
For cloning, PCR amplification products from serum were digested with
the restriction enzymes
ApaI and
KpnI (both from
New
England BioLabs) and ligated into an appropriately cut pGEM-7Zf(+)
vector (Promega) by using a rapid DNA ligation kit (Roche Molecular
Biochemicals, Indianapolis, Ind.). Recombinant plasmids were cloned
into DH5

bacterial cells (GIBCO/BRL, Gaithersburg, Md.).
DNA sequencing of PCR-amplified products and cloned DHBV
DNA.
For direct sequencing, the biotinylated PCR products were
adsorbed to streptavidin-coated beads (Dynabeads M-280; Dynal A.S., Oslo, Norway) and washed according to the manufacturer's instructions with the help of a magnetic particle concentrator (Dynal catalogue no.
120.04; Dynal A.S.). The nonbiotinylated minus-strand products were
released from the beads by denaturation in 0.1 N NaOH, and the
biotinylated plus-strand products were sequenced on the beads with 5 pmol of P2 and 35S-dATP using the T7 Sequenase version 2.0 dGTP reagent kit (Amersham Life Science, Cleveland, Ohio).
The sequence of cloned PCR products was determined by using primers P3
(5'-TTGGCCTGCTGGGGCGGGAA, nt 992 to 1011, sense), P4
(5'-GGTGGTTTCCGGTGGTCTTT, nt 1136 to 1117, reverse),
M13reverse
(Stratagene, La Jolla, Calif.), and M13(

20)forward
(Stratagene).
Cloning of PCR-derived DNA into replication-competent
genomes.
Six candidate revertant mutations identified by
sequencing of PCR amplification products of the pre-S region were
cloned into the DHBV-16 WT genome. PCR products amplified with P1 and
P2 (see above) were purified by phenol extraction, precipitated with
ethanol, and digested with the restriction enzymes PflF1 and
XhoI or KpnI (all from New England BioLabs)
respectively. Subsequently, they were subjected to low-melting-point
agarose electrophoresis (GIBCO/BRL) and visualized by ethidium bromide
staining. The bands of interest were cut out under low-wave UV
illumination and, after heating to 65°C, directly used for ligation
into the DHBV-16 WT genome construct which had been digested with the
appropriate restriction enzymes to remove the corresponding WT pre-S
sequences. Ligation was performed with T4 DNA ligase (GIBCO/BRL)
overnight at 14°C. DH5
bacterial cells (GIBCO/BRL) were used for cloning.
 |
RESULTS |
The purpose of this study was to determine the spontaneous
mutation rate during an experimental infection of young ducklings with
the avian hepadnavirus DHBV. We used the reversion rate of a cytopathic
variant of DHBV as a measure of mutation rate. Noncytopathic revertants
are easily detected, since we previously showed that they are rapidly
selected in vivo (16). In addition, we sought to identify
the sites of the various mutations in the DHBV genome that cause
reversion of the cytopathic phenotype.
Strategy and rationale of the experiment.
Previous studies
have shown that infection of ducklings with a variant of DHBV of the
viral large envelope (pre-S) domain, namely, G133E, was cytopathic for
the birds, leading to severe acute but transient noninflammatory liver
injury (17). Recovery from acute liver disease was shown
to be accompanied by the appearance of noncytopathic spontaneously
arising revertant viruses (16). At the molecular level,
hepatocellular injury was preceded by elevated levels of DHBV cccDNA in
the hepatocytes, and enhanced cytoplasmic staining for viral capsid
proteins was observed within the cells. A single amino acid change of
glycine to glutamic acid at position 133 (G133E) in the pre-S domain of
DHBV was directly responsible for these phenomena, as the production of
new viral cccDNA in hepatocytes is regulated by the viral pre-S protein (27). It is believed that WT pre-S protein directs capsids
containing relaxed circular DNA, the precursor of cccDNA, into a
pathway for assembly of virus particles, which are secreted from the
infected cells, excluding their utilization for cccDNA synthesis in the nuclei, possibly through direct interaction with the capsid protein of
the virus itself (14).
In previous work, we showed that authentic WT DHBV added to the G133E
inoculum could be detected among the population of noncytopathic
viruses that grew out during recovery from acute liver injury
(
16). Hence, WT virus, when added in known amounts to the
G133E
inoculum, could be used as an internal reference for measuring
the frequency of spontaneous mutants that behave like WT virus
during
outgrowth. Noncytopathic mutants were expected to carry
a same-site
mutation or various second-site suppressor mutations
in the pre-S
envelope gene and could be identified by sequencing.
We assumed that
the frequency at which any such mutant arises
reflects the mutation
rate at that
nucleotide.
The amount of each spontaneous revertant in the final noncytopathic
virus population was compared with the amount of reference
WT virus to
determine approximately how frequently that revertant
was generated and
replicated compared to parental virus during
outgrowth of the parent
virus in vivo. The frequency of each revertant
was calculated as the
ratio of that revertant to WT virus in the
final noncytopathic virus
population, multiplied by the ratio
of WT virus to G133E virus in the
inoculum. Because multiple rounds
of infection occur in vivo, and the
reversion frequency is a cumulative
measure of the revertants present
in the inoculum plus those generated
in each round of infection, the
reversion frequency is dependent
on the amount of virus replication
during spread of infection
and replacement (see
Appendix).
Viremia and weight gain after mixed infection.
In experiment
1, a total of 24 ducklings (six groups consisting of four birds each)
were infected at 4 days of age with inocula of 108 viral
genomes of G133E, either alone (group 1) or mixed with WT DHBV at a
frequency of 10
2 to 10
6 WT genomes per
G133E genome (groups 2 to 6, respectively). One group of three
ducklings was infected with 108 genomes of WT virus only
(group 7). Three birds that served as uninfected controls received no
inoculum (group 8). Ducklings were bled and weighed daily from day 3 to
day 14 and at 21 and 25 days postinfection. The presence of viral DNA
in the serum was monitored by PCR, and the respective viral DNA titers
were determined by dot hybridization and phosphorimaging.
The amount of DHBV DNA (mean log molecules per milliliter) detected in
serial bleeds collected over the course of experiment
1 from all groups
of birds is shown in Fig.
1. Viremia
achieved
an early maximum already by day 6 postinfection in WT
virus-infected
birds (group 7), whereas virus levels in G133E-infected
birds
(group 1) or mixed-infection groups (groups 2 to 6) peaked at
slightly later times. Viremia in the serum declined or fluctuated
over
time after its peak in all groups of ducklings. Virus was
not detected
in any birds from the uninfected control group 8.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Viremias in eight groups of ducklings. Viremias were
determined by dot hybridization and phosphorimaging. The minimum
viremia detectable by this method was approximately 2 × 106 genomes per ml. The mean log value for all positive
samples within a group for each time point was plotted.
|
|
The mean body weights for all eight groups of ducklings are shown in
Fig.
2. As previously reported, infection
with G133E
resulted in a retardation of the normal rapid growth.
Coinfection
with WT virus caused a moderation of this effect, seemingly
in
proportion to the amount of WT virus included in the inoculum.
This
moderating effect may be due to protection of hepatocytes
infected with
WT virus from damage caused by G133E. The transient
retardation of
growth in G133E-infected ducklings reflects the
previously demonstrated
hepatocytopathic effect of the mutant
virus, and the resumption of
normal weight gain is due to the
replacement of the cytopathic virus
population with noncytopathic
viruses (
16).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Body weights in eight groups of ducklings. All birds in
each group were weighed at the indicated times, and the mean body
weight at each time point was plotted.
|
|
Outgrowth of WT and putative revertant viruses in mixed infections
with G133E and WT virus.
To see whether recovery from liver
disease reflected by the resumption of normal growth was primarily due
to outgrowth of WT virus or to spontaneous revertants in
mixed-virus-infected birds (groups 2 to 6), we carried out PCR
amplifications of the DHBV region which carries the genetic tag and
G133E mutation and assayed for the presence (WT virus population) or
absence (G133E and/or spontaneous revertant population) of the
SmaI site at position 1178. As seen in Fig.
3, the PCR products obtained from the
serum of ducklings from groups 5 and 6 lacked any detectable
SmaI cleavage. These virus populations therefore consisted
predominantly of spontaneous revertants and G133E virus with no
detected WT internal standard. In contrast, in serum samples from birds
infected with larger amounts of WT internal standard added to the
inoculum (groups 2, 3, and 4), SmaI-digestible viral DNA
appeared during the course of the experiment in amounts that were
directly related to the presence of WT virus in the inoculum. These
results suggested that, by 21 days postinfection, coincident with
recovery from acute liver injury, the major virus population found in
the serum of ducklings shifted from the G133E genotype to the WT
genotype (group 2) mixed with spontaneous revertant genotypes (groups 3 to 6). Accordingly, the frequency of all spontaneous revertants would
be approximately equal to the proportion of WT reference virus in the
inoculum that produced an equal mixture of WT and revertant virus in
the ducklings at 21 days. (After melting and reannealing during the
final cycles of PCR, only 25% of double-stranded products would
contain SmaI sites in both strands and be digested with
SmaI.) In this experiment, the inoculum most closely
producing such a mixture was that containing WT virus at a frequency of 10
4.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
PCR assay of the emergence of WT virus in ducklings with
mixed infections. Serum samples from individual infected ducks,
represented in separate lanes, were amplified by PCR. The products were
each mixed with 600 ng of pGEM-7Zf(+) DNA and digested with
SmaI to detect the appearance of WT internal reference
genomes. The upper band (C) is the control added to each reaction
mixture to monitor for complete digestion. The double bands represent
the undigested PCR product of G133E-derived genomes (G) and the
digested product of WT internal reference genomes (W).
|
|
To confirm the presence of potential spontaneous revertants and WT
internal reference genomes in the serum of different animals,
we
directly sequenced the PCR amplification products obtained
from birds
of groups 2, 4, and 6 by day 21 postinfection. The
results obtained
from one animal in each of the respective groups
are shown in Fig.
4. Consistent with the data shown in Fig.
3,
no WT internal reference was present in the direct sequence from
a
bird of group 6, as indicated by the absence of a WT-specific
band (C)
at the
SmaI site (CC
CGGG). In groups 2 and 4, both the
WT-specific band (C) and the G133E-specific band (G) could be
seen in the mass sequence, with the G band being enriched in the
sequence from group 4 birds. No putative spontaneous revertants,
indicated by minor bands marked with arrows, were detectable in
the
direct sequence of the PCR amplification product in the bird
from group
2 (the nucleic acid sequence at position 1198 of the
pre-S region
showed either WT GGA for glycine or cytopathic mutant
GAA for
glutamate). A population of various potential spontaneous
revertants
was visible in the direct sequences from birds of groups
4 and 6.

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 4.
Direct sequence of PCR products derived from
representative birds in groups 2, 4, and 6. Sequencing reactions were
performed on biotinylated PCR products as described in the text. The
sequence ladder runs from bottom to top in the plus-strand direction.
The positions of the SmaI site present in the WT internal
reference and codon 133 are indicated. Arrows mark sites of potential
reverting mutations. aa, amino acid.
|
|
Nature and location of mutations in the pre-S region of spontaneous
revertant viruses.
In order to resolve the individual spontaneous
revertant sequences in G133E-infected ducklings, we cloned and
sequenced the C-terminal region of the pre-S domain obtained from PCR
products of four mixed-virus-infected birds from group 4 at various
time points postinfection. In one bird (no. 440), pre-S sequences were analyzed at multiple times during infection. In a second bird (no.
438), the only viremic serum sample available was from 5 days
postinfection, and all subsequent samples were negative by PCR. A total
of six libraries of cloned pre-S sequences were prepared, and up to 31 separate sequences were determined for each library. As listed in Table
1, a spectrum of amino acid changes and
corresponding codon changes was observed in the libraries, with the
libraries from 3 and 5 days postinfection showing little heterogeneity, while libraries prepared from later time points contained various amounts of the internal reference WT virus and low amounts of the
cytopathic virus G133E. The remaining sequences in the libraries from
14 and 21 days postinfection contained the G133E-specific genetic tag
accompanied by changes at one residue (86 of 93) or occasionally a
second residue (14 of 86). In cases where mutations occurred at two
sites, one of these mutations was usually a unique example (one
exception, E133K + Q135R) and was considered to be possibly
introduced by PCR. This interpretation is consistent with the observed
frequency of single mutations in the WT internal reference genomes
sequenced (1 of 17), which is not significantly different.
A total of eight mutations were found in more than one library, and
seven of these were considered to be candidate noncytopathic
revertants. Of these, the codon 133 mutant, E133G, representing
a true
reversion to WT, was observed in samples analyzed from
three different
birds. Major second-codon mutations resulted in
the substitutions
D129E, Q135R, Q135H, and T140I. Two of these
substitutions (D129E and
Q135H) were generated by alternative
codon changes (Table
1). The
remaining commonly found mutation
was the substitution E133K. This
mutation, previously shown to
retain a cytopathic phenotype, was always
present in the population
of revertants, especially during the earlier
times, and decreased
in frequency at later times (compare 14 and 21 days, bird 440).
Because this mutant is cytopathic, shows a unique
dynamics of
appearance, and is unable to compete with true revertants
(
14;
data not shown), we chose to exclude it from the
analysis of revertant
frequencies. We do not understand the behavior
associated with
the emergence of this
mutant.
Functional tests of candidate pre-S mutants.
To test whether
the growth rates of the candidate spontaneous revertants allowed them
to expand in parallel with the WT internal reference, we determined
their ability to compete with the WT virus in a mixed infection of
ducklings. Pre-S regions containing the four observed codon changes
resulting from the six mutations observed in more than one library were
substituted into a WT genome and transfected into LMH cells. To verify
the absence of additional mutations, the whole pre-S region between the
sites used for cloning was sequenced in each construct. Virus stocks of
revertants were prepared, and ducklings were inoculated together with
WT virus in a 1:1 ratio (experiment 2). To estimate the ability of the cytopathic virus to compete with WT, G133E was also included among the
combinations of mixed infections. The region of viral DNA containing
the genetic tag was amplified from the earliest virus-positive serum
sample from each bird, and the PCR products were subjected to
SmaI digestion and agarose gel electrophoresis. The data
obtained are shown in Fig. 5.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 5.
PCR assay for the genotype of virus in ducks with mixed
infections. The first viremic serum sample from each group of ducklings
infected with WT plus the indicated candidate revertant was amplified
by PCR, and the products were mixed with pGEM DNA and digested with
SmaI exactly as described for Fig. 3. The positions of the
control (C), the G133E-specific (G), and the WT-specific (W) bands are
indicated.
|
|
Although the cytopathic G133E virus had been previously shown to
produce transiently higher levels of virus than did WT in
a primary
duck hepatocyte infection, its presence was not detected
in the viremic
serum samples when competed with WT. This result
indicates that the
cytopathic virus sustained a growth disadvantage
during spread of
infection in the liver in spite of its transiently
elevated virus
release. E133G virus, the same-site revertant,
maintained a 1:1 ratio
to WT virus during outgrowth in vivo as
expected. The same was true for
all second-site revertants tested
in different birds, with the possible
exception that the T140I
second-site mutant was slightly decreased
below WT after outgrowth.
These results, to a first approximation,
justify the use of the
internal reference WT virus to estimate the
revertant frequencies
at the various sites detected, since the WT and
revertant populations
expand in parallel. The data also provide
indirect evidence that
the putative revertants were probably
noncytopathic since the
cytopathic phenotype of G133E (Fig.
5) and of
E133K (data not
shown) apparently caused a reduction in its rate of
spread during
infection in
vivo.
Frequency of revertants.
For estimating the frequencies of the
various spontaneous revertants, the ratios of seven spontaneous
revertants which occurred most often in the viral population to the WT
internal standard were calculated by dividing the total number of
respective revertant clones observed by the number of WT clones
observed in the libraries. The frequency of WT clones in this viral
population was defined as 10
4 per G133E genome, since, in
group 4, WT virus had been added to the inoculum at a frequency of
10
4. As seen in Table 2,
the relative mutation frequencies for these specific sites in the DHBV
genome varied from 1 × 10
5 to 6 × 10
5, with the same-site reversion being present at the
highest frequency.
Types of mutations observed.
The mutations observed in the
seven authentic revertants included three transitions and four
transversions. In contrast, the remaining 16 sporadic mutations
observed consisted of 12 transitions and 4 transversions. Whether the
different ratios of transitions to tranversions in the two groups of
mutants are significant and reflect two different mechanisms for
generating mutations is not known (e.g., errors in replication versus
PCR-generated errors). No deletions were detected, and this is not
surprising because of the high degree of selection for function in this system.
 |
DISCUSSION |
In the previous studies cited, we demonstrated that infection of
young ducklings with a cytopathic hepadnavirus, G133E, resulted in
acute noninflammatory liver injury, followed within 2 to 3 weeks by
recovery and restoration of normal liver histology. Recovery was
attributed to the emergence of spontaneous noncytopathic revertants, which replaced the cytopathic virus in the liver. Thus, liver injury
likely reflected the process of virus replacement, with G133E-infected
cells dying and being replaced by revertant-infected cells. Infection
with the cytopathic virus could therefore be considered to be
transient, involving a limited amount of virus replication before
elimination from the liver.
In this study, we determined how frequently revertant viruses were
produced during the transient G133E replication that occurred in this
system. The frequency of revertant production may be taken as a crude
measure of the rate at which hepadnaviruses generate variants by
spontaneous random mutation. To measure the frequency of reversion, we
utilized a genetically marked WT virus as an internal reference. Since
true revertants, by definition, would be indistinguishable from the WT
reference in their growth and subsequent selection in the duckling, the
ratio of such revertants to the WT reference could be used to calculate
the total number of revertants generated.
For example, in an inoculum containing 108 G133E virus
produced from transfected plasmid DNA, and a reversion rate at a single site of 10
5 per G133E genome synthesized, the
corresponding revertant population would be 103 virus
particles. After addition to the inoculum of 104 WT virus
as the internal reference and injection into ducklings, each infecting
viral genome would be converted to cccDNA and begin to produce progeny
cccDNA by intracellular amplification and extracellular spread of
infection. The increase in cccDNA derived from the input revertant
genomes would exactly parallel the increase in cccDNA from the WT
reference virus; however, revertant genomes would continue to be
generated de novo as a by-product of the replication of G133E cccDNA.
These new cohorts of revertants will be converted to cccDNA and
replicate, also expanding in parallel with the WT internal reference
population. As a result, as all three virus populations expand in vivo,
and new cohorts of revertants are generated from the parental G133E,
the ratio of revertant virus to WT virus will increase over time. As
the proportion of replicating G133E genomes diminishes due to death of
infected cells or overgrowth of WT and revertant cccDNA, new cohorts of
revertants contributed by G133E replication become less significant,
and eventually the ratio of revertants and WT virus stabilizes. The
final ratio is a measure of the sum of the revertants present in the
inoculum plus those generated in vivo and the total WT reference in the inoculum. Since the ratio of WT reference virus to G133E in the inoculum is known, the amount of each revertant per inoculated G133E
genome accumulated over multiple generations required for spread of
infection throughout the liver can be inferred. In our experiments, the
frequency of revertants determined in this manner was between 1 × 10
5 and 6 × 10
5 per G133E genome inoculated.
The relationship between the frequency of revertants that we measured
and the mutation rate, i.e., the probability of mutation per nucleotide
per generation, is complex because we have measured the frequency of
specific mutations over an unknown number of generations of G133E DNA
replication. In a mathematical model presented in the Appendix, we have
estimated that the final frequency of each specific revertant in our
experiment is probably between 4- and 23-fold higher than the reversion
rate at that site. For the same-site revertant, E133G, which grows at
the same rate as does WT virus, the final revertant frequency was 6 × 10
5, implying that the rate of the mutation E133G was
between 0.26 × 10
5 and 1.5 × 10
5 per generation. Accordingly, the error rate for all
three possible substitutions at this position would be 0.8 × 10
5 to 4.5 × 10
5 errors per genome
synthesized, or one error per 7 to 42 viral genomes synthesized. All
specific second-site revertants were found at somewhat lower
frequencies (Table 2), suggesting that these revertants may have
replicated at a slightly reduced rate compared with that of the true WT
revertant (E133G) and the reference virus, even though a reduced
replication rate was not detected in the competition experiment. In
support of this notion, the revertant T140I, which was present at the
lowest frequency, appeared to undergo a weak negative selection in
mixed infection with WT. In addition, error frequencies may differ at
different positions and for specific substitutions (6, 9).
In this limited survey, substitutions at three sites in the vicinity of
residue 133, namely, amino acids 129, 135, and 140, were able to revert
the G133E cytopathic phenotype, presumably by restoring the normal
function of the pre-S protein in virus release and cccDNA regulation.
This result does not necessarily mean that the region inclusive of
amino acids 129 to 140 is part of a functional site of interaction of
the pre-S protein with its ligand, e.g., mature capsids. It is not
known how the G133E mutation affects pre-S function in virus production
and regulation of cccDNA synthesis. While the mutation may directly
alter a functional site on the protein, it is also possible that the
formation of a domain of the protein that contains the functional site
is affected by the mutation, or that the G133E mutation causes a
partial folding defect resulting in reduced amounts of properly folded
protein. Each such defect could potentially be suppressed by
substitution of amino acids neighboring the original mutation.
Interestingly, the glutamate at position 133 of the pre-S open reading
frame, known to be cytopathic in the context of DHBV-16, is naturally
present in most DHBVs of Chinese or Australian origin without apparent
cytopathicity (28). These viruses all carry a lysine at
position 135 of the pre-S protein and not a glutamine, as does DHBV-16.
The selection for revertants with Q135R or Q135H as second-site
mutations might therefore be anticipated if certain basic amino acid
side chains at this position can suppress the phenotype resulting from
a glutamate at position 133. Although the subsititution Q135K can
theoretically be generated by a single nucleotide substitution
(CAG
AAG), this change would introduce a stop codon (TCA
TAA) in
the overlapping P open reading frame and would be inconsistent with
viability. While P gene mutations may be generated during the reverse
transcription step, genomes bearing these mutations were unlikely to be
propagated during expansion of the revertant pool.
We do not understand the early emergence of the mutant E133K from the
population of cytopathic viruses and its later decline seen for bird
440 (Table 1). We previously showed that this mutant is unable to
compete effectively with WT virus in a mixed infection and that
infection of ducklings with the E133K virus produces an acute liver
injury similar to that seen with G133E (16). It is
possible that initially this mutant had some undefined advantage over
WT revertants that was confined to early stages of infection of the
duckling and that the cytopathic phenotype caused rapid selection
against it during later stages. Alternatively, the mutant may be
generated by an extraordinarily high mutation frequency at position
1199. We have not adequately tested either of these possibilities.
 |
APPENDIX |
In the experiments described in this paper, we infected
ducklings with inocula containing three types of viruses: a cytopathic virus, G133E (G); a genetically marked WT reference virus (W); and
spontaneous revertants of G133E (R) produced as a result of errors in
replication. Here we examine how the spontaneous revertants are
predicted to accumulate relative to the WT reference virus as the
population of the G133E parent expands and is displaced by WT and
revertant virus in the liver.
The model. Since the spontaneous revertants were
produced in a transfection of plasmid G133E DNA, we assume that they arose in a single cycle of transcription and DNA synthesis and therefore that any particular revertant R1 was present in
the G-containing inoculum in an amount R1(0) = G(0) × m1, where m1 is
the probability of formation of a particular revertant per G133E genome
synthesized and R1(0) and G(0) represent the fraction of
liver cells infected by R1 and G, respectively, at
t = 0. The complete collection of possible revertants
at t = 0, R(0), can be represented by R(0) = R1(0) + R2(0) +...+
Rn(0) = G(0) × m, where
m = m1 + m2
+... mn. During the spread of
infection, assuming that m << 1, and neglecting back
mutations, the increase in the three virus populations is described by
the following set of equations:
where U(
t) is the fraction of the liver that
is uninfected;
kg,
kr, and
kw are the rate constants for
synthesis of G, R,
and W, respectively; and
kd is the rate constant for loss of G
by death of G133E-infected cells. In this model, the following
assumptions are made. (i) Expansion of virus into the uninfected
liver
proceeds according to first-order kinetics. (ii) Death of
G133E-infected cells proceeds according to first-order kinetics.
(iii)
Loss of G133E by cell death does not result in loss of W
or R. (iv)
Death of G133E-infected hepatocytes results in the
immediate production
of new hepatocytes susceptible to infection
by any of the three
viruses. (v) The size of the liver does not
change. While none of these
assumptions is strictly true, deviation
of the model from the actual
conditions does not substantially
change the final outcome with respect
to how the revertant-to-WT
ratio changes over time. The reason for this
is that the majority
of the increase in the revertant-to-WT ratio
occurs during the
expansion of the G133E population into the uninfected
liver, when
the three virus populations are growing independently and
there
is an excess of uninfected
cells.
Initial values. The values for G(t),
R(t), and W(t) were calculated using numerical
integration to visualize the expansion of the three virus populations
in the liver and the replacement of G133E and to determine the final
R/W ratio. In these calculations, we assumed that the inoculum of
108 viral genomes resulted in infection of 1:1,000 of the
liver, i.e., G(0) = 10
3. The reversion rate,
m, was arbitrarily set equal to 10
5 per
genome, so that R(0) = 10
8. W(0) was set equal to
R(0). Therefore, the ratio R(t)/W(t) indicates the increase in the frequency of revertants over the reversion rate due
to the accumulation of revertants through multiple generations. The
values for the various rate constants were chosen with the following
rationale. Since the experiment in Fig. 5 shows that, in the viremia
resulting from inoculation of ducklings with a 1:1 mixture of WT and
G133E, G133E was not detected, we conclude that the net rate of virus
spread of G133E when U ~ 1 is less than that of WT virus.
Therefore, (kg
kd) < kw. It is known that G133E-infected
primary duck hepatocytes transiently produce cccDNA and virus at higher
levels than do WT-infected cells (15) and therefore
kg > kw. We set the rate constant for WT
cccDNA synthesis equal to 1.6 day
1 (11, 12)
and varied kg at between 1.6 and 8.0 day
1. Calculations were run with values of
kd adjusted so that the net growth
rate of G133E was between 0.5 and 0.9 times the WT growth rate. Values
for G(t), R(t), and W(t) were
determined over a period of 25 days. In all runs using the criteria
listed above, the R(t)/W(t) ratio stabilized
within 25 days. The results of a run using values of
kg and
kg
kd in the midrange of the values tested are shown in Fig. A1A, and a
plot of the R(t)/W(t) ratio is shown in Fig. A1B.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. A1.
Simulated growth of three virus populations in the
liver of an infected duckling. (A) Numerical calculations of the
fraction of liver infected with G133E (G), G133E revertant (R), and WT
viruses (W). Initial conditions were m = 10 5 revertants/genome synthesized, G(0) = 10 3, R(0) = 10 8 [R(0) = m × G(0)], W(0) = 10 8,
kw = 1.6 day 1,
kr = kw,
kg = 3.2 day 1, and
kd = 1.92 day 1
[(kg kd)/kw = 0.8].
Calculations were run over a simulated time of 25 days. (B) R/W ratio
during the simulation in panel A.
|
|
A series of calculations varying kg
and kg
kd as indicated above was performed,
the final ratio R/W at 25 days was determined, and the values are
plotted in Fig. A2. It can be seen that
the increase in the ratio of revertant to the WT internal reference occurring after maximum expansion of the G133E population is directly dependent on both the relative growth rate of G133E,
kg, and the net growth rate of G133E,
kg
kd. The dependence on
kg is due to the increased rate of
revertant production. The dependence on the net growth rate,
kg
kd, is due to the prolonged ability of G133E to compete with preexisting WT and revertants during the G133E
expansion and thereby to continue to add significant cohorts of
revertants to the replicating revertant pool. Moreover, these results
also apply to the increase in ratio of each individual revertant to WT
since the outcome of the model is relatively independent of the actual
mutation rate and all revertants grow in parallel.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. A2.
Accumulation of revertants as a function of the growth
properties of G133E. Calculations similar to those shown for Fig. A1
were performed using the indicated growth rate constant
(kg) and the net growth rate constant
(kg kd) for G133E. The
rate constants were normalized to that of WT
(kw). The ratio of revertant to WT virus (R/W)
at 25 days postinfection is plotted. Since R(0)/W(0) = 1, the
ratio R/W represents the excess revertant accumulation due to growth of
G through multiple generations.
|
|
In the experiments, we measured the ratio of a specific revertant,
E133G, to WT to be approximately 0.6 after replacement of G133E in the
liver. To calculate limits on the inferred ratio of this revertant to
WT in the inoculum, we may refer to Fig. A2, which indicates that the
increase in the ratio over that in the inoculum would lie in the range
between approximately 4- and 23-fold (3.97 to 22.8). Accordingly, we
estimate the ratio in the inoculum to have been between 0.026 and 0.15. Since WT reference virus in the inoculum was present at a frequency of
10
4, the E133G revertant would have been present at a
frequency of 0.26 × 10
5 to 1.5 × 10
5. We take this to be the specific reversion rate per
viral genome synthesized. Because this reversion corresponds to a
specific nucleotide substitution, the total error rate per nucleotide
per genome would be three times the specific error rate or 0.8 × 10
5 to 4.5 × 10
5 per nucleotide per
genome synthesized.
 |
ACKNOWLEDGMENTS |
We thank Wengang Yang and Francis Lim for valuable suggestions
and advice during the course of these experiments, Wengang Yang for
inoculating ducklings in experiment 1, and William S. Mason, Fox Chase
Cancer Center, for helpful discussions and critical reading of the manuscript.
This work was supported by grants CA42542 and CA84017 from the National
Cancer Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, The University of New Mexico, 900 Camino de Salud, Albuquerque, NM 87131. Phone and fax: (505) 272-8896. E-mail: jsummer{at}unm.edu.
 |
REFERENCES |
| 1.
|
Allen, M. I.,
M. Deslauriers,
C. W. Andrews,
G. A. Tipples,
K. A. Walters,
D. L. Tyrrell,
N. Brown, and L. D. Condreay.
1998.
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine.
Hepatology
27:1670-1677[CrossRef][Medline].
|
| 2.
|
Argentini, C.,
V. La Sorsa,
R. Bruni,
E. D'Ugo,
R. Giuseppetti, and M. Rapicetta.
1999.
Hepadnavirus evolution and molecular strategy of adaptation in a new host.
J. Gen. Virol.
80:617-626[Abstract].
|
| 3.
|
Blackberg, J., and K. Kidd-Ljunggren.
2000.
Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation.
J. Hepatol.
33:992-997[CrossRef][Medline].
|
| 4.
|
Carman, W. F.
1997.
The clinical significance of surface antigen variants of hepatitis B virus.
J. Viral Hepatitis
4:11-20.
|
| 5.
|
Domingo, E.,
C. Escarmis,
L. Menendez-Arias, and J. J. Holland.
1999.
Viral quasispecies and fitness variations, p. 141-161.
In
E. Domingo, R. Webster, and J. Holland (ed.), Origin and evolution of viruses. Academic Press, Inc., San Diego, Calif.
|
| 6.
|
Durbin, R. K., and V. Stollar.
1986.
Sequence analysis of the E2 gene of a hyperglycosylated, host restricted mutant of Sindbis virus and estimation of mutation rate from frequency of revertants.
Virology
154:135-143[CrossRef][Medline].
|
| 7.
|
Girones, R., and R. H. Miller.
1989.
Mutation rate of the hepadnavirus genome.
Virology
170:595-597[CrossRef][Medline].
|
| 8.
|
Gunther, S.,
L. Fischer,
I. Pult,
M. Sterneck, and H. Will.
1999.
Naturally occurring variants of hepatitis B virus.
Adv. Virus Res.
52:25-137[Medline].
|
| 9.
|
Hahn, C. S.,
C. M. Rice,
E. G. Strauss,
E. M. Lenches, and J. H. Strauss.
1989.
Sindbis virus ts103 has a mutation in glycoprotein E2 that leads to defective assembly of virions.
J. Virol.
63:3459-3465[Abstract/Free Full Text].
|
| 10.
|
Hannoun, C.,
P. Horal, and M. Lindh.
2000.
Long-term mutation rates in the hepatitis B virus genome.
J. Gen. Virol.
81:75-83[Abstract/Free Full Text].
|
| 11.
|
Jilbert, A. R.,
J. S. Freiman,
C. J. Burrell,
M. Holmes,
E. J. Gowans,
R. Rowland,
P. Hall, and Y. E. Cossart.
1988.
Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver.
Gastroenterology
95:1375-1382[Medline].
|
| 12.
|
Jilbert, A. R.,
D. S. Miller,
C. A. Scougall,
H. Turnbull, and C. J. Burrell.
1996.
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
Virology
226:338-345[CrossRef][Medline].
|
| 13.
|
Kawaguchi, T.,
K. Nomura,
Y. Hirayama, and T. Kitagawa.
1987.
Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH.
Cancer Res.
47:4460-4464[Abstract/Free Full Text].
|
| 14.
|
Lenhoff, R. J., and J. Summers.
1994.
Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.
J. Virol.
68:4565-4571[Abstract/Free Full Text].
|
| 15.
|
Lenhoff, R. J., and J. Summers.
1994.
Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes.
J. Virol.
68:5706-5713[Abstract/Free Full Text].
|
| 16.
|
Lenhoff, R. J.,
C. A. Luscombe, and J. Summers.
1998.
Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
Virology
251:85-95[CrossRef][Medline].
|
| 17.
|
Lenhoff, R. J.,
C. A. Luscombe, and J. Summers.
1999.
Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
Hepatology
29:563-571[CrossRef][Medline].
|
| 18.
|
Mandart, E.,
A. Kay, and F. Galibert.
1984.
Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences.
J. Virol.
49:782-792[Abstract/Free Full Text].
|
| 19.
|
Mansky, L. M., and H. M. Temin.
1995.
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.
J. Virol.
69:5087-5094[Abstract].
|
| 20.
|
Mutimer, D.
1998.
Hepatitis B virus antiviral drug resistance: from the laboratory to the patient.
Antivir. Ther.
3:243-246[Medline].
|
| 21.
|
Netter, H. J.,
S. Chassot,
S. F. Chang,
L. Cova, and H. Will.
1997.
Sequence heterogeneity of heron hepatitis B virus genomes determined by full-length DNA amplification and direct sequencing reveals novel and unique features.
J. Gen. Virol.
78:1707-1718[Abstract].
|
| 22.
|
Okamoto, H.,
M. Imai,
M. Kametani,
T. Nakamura, and M. Mayumi.
1987.
Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission.
Jpn. J. Exp. Med.
57:231-236[Medline].
|
| 23.
|
Pathak, V. K., and H. M. Temin.
1990.
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations.
Proc. Natl. Acad. Sci. USA
87:6019-6023[Abstract/Free Full Text].
|
| 24.
|
Pugh, J. C.,
K. Yaginuma,
K. Koike, and J. Summers.
1988.
Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro.
J. Virol.
62:3513-3516[Abstract/Free Full Text].
|
| 25.
|
Pult, I.,
T. Chouard,
S. Wieland,
R. Klemenz,
M. Yaniv, and H. E. Blum.
1997.
A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B.
Hepatology
25:1507-1515[CrossRef][Medline].
|
| 26.
|
Summers, J., and W. S. Mason.
1982.
Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate.
Cell
29:403-415[CrossRef][Medline].
|
| 27.
|
Summers, J.,
P. M. Smith,
M. Huang, and M. Yu.
1991.
Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus.
J. Virol.
65:1310-1317[Abstract/Free Full Text].
|
| 28.
|
Triyatni, M.,
P. Ey,
T. Tran,
M. Le Mire,
M. Qiao,
C. Burrell, and A. Jilbert.
2001.
Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses.
J. Gen. Virol.
82:373-378[Abstract/Free Full Text].
|
| 29.
|
Zhang, Y. Y., and J. Summers.
2000.
Low dynamic state of viral competition in a chronic avian hepadnavirus infection.
J. Virol.
74:5257-5265[Abstract/Free Full Text].
|
Journal of Virology, October 2001, p. 9623-9632, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9623-9632.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stoeckl, L., Funk, A., Kopitzki, A., Brandenburg, B., Oess, S., Will, H., Sirma, H., Hildt, E.
(2006). Identification of a structural motif crucial for infectivity of hepatitis B viruses. Proc. Natl. Acad. Sci. USA
103: 6730-6734
[Abstract]
[Full Text]
-
Wieland, S. F., Chisari, F. V.
(2005). Stealth and Cunning: Hepatitis B and Hepatitis C Viruses. J. Virol.
79: 9369-9380
[Full Text]
-
Tang, H., McLachlan, A.
(2002). Avian and Mammalian Hepadnaviruses Have Distinct Transcription Factor Requirements for Viral Replication. J. Virol.
76: 7468-7472
[Abstract]
[Full Text]
-
Kidd-Ljunggren, K., Miyakawa, Y., Kidd, A. H.
(2002). Genetic variability in hepatitis B viruses. J. Gen. Virol.
83: 1267-1280
[Abstract]
[Full Text]
-
Yamamoto, T., Litwin, S., Zhou, T., Zhu, Y., Condreay, L., Furman, P., Mason, W. S.
(2002). Mutations of the Woodchuck Hepatitis Virus Polymerase Gene That Confer Resistance to Lamivudine and 2'-Fluoro-5-Methyl-{beta}-L-Arabinofuranosyluracil. J. Virol.
76: 1213-1223
[Abstract]
[Full Text]